The ‘Global Cancer Screening Market Size, Share, Price, Trends, Growth, Analysis, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global cancer screening market, assessing the market on the basis of its segments like cancer type, technique, stage, gender, and major regions.
The report studies the latest updates in the market, along with their impact across the market. It is also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
Cancer Screening Market Share, Size, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2018-2028)
• Forecast CAGR (2023-2028): 9%
The increasing prevalence of cancer across the world is leading to an increase in focus on early detection and treatment. Brutal cancers related to blood, lung, and skin, among others, are growing at a robust pace. Unhealthy lifestyles led by the working population, coupled with the increasing number of smokers, are some of the key cancer screening market driving factors. In addition, increasing awareness pertaining to the growing fatalities due to cancer is being witnessed.
Get a Free Sample Report with a Table of Contents@ https://www.expertmarketresearch.com/reports/cancer-screening-market/requestsample
Favorable initiatives by various governments aimed at improving the healthcare infrastructure and curbing cancer cases are further spreading awareness among people about cancer screening. Meanwhile, the growing mergers and collaborations between prominent healthcare firms aimed towards improving timely cancer diagnosis and treatment are providing impetus to the global cancer screening market.
Technological advancements in imaging techniques with high-resolution visualisation devices are expected to increase the efficiency and reliability of cancer screening. The growing sophistication of cancer screening equipment is likely to accelerate the market numbers in the forecast period.
Cancer Screening Industry Definition and Major Segments
Cancer screening is a testing process that aims at detecting cancer at an early stage where there are no active symptoms of cancer, facilitating early treatment, and reducing the risk of fatalities. Cancer screening improves the effectiveness of the cancer treatment process by targeting the growth of cancerous cells at the initial stages.
Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/cancer-screening-market
Based on cancer type, the market can be segmented into:
• Lung Cancer
• Blood Cancer
• Bone Cancer
• Gall Bladder Cancer
• Testicular Cancer
• Thyroid Cancer
• Breast Cancer
On the basis of technique, the market has been classified into:
• Imaging Techniques
o CT Scan
• Biopsy and Cytology Tests
o Needle Biopsy
o CT – Guided Biopsy
• Genomic and Molecular tests
o Next Generation Sequencing (NGS)
o RT- PCR
Based on stage, the market can be categorised into:
• TNM Stages
• Stages 0, 1, 2, 3, 4
• Prognostic Factors
By gender, the market has been divided into:
On the basis of region, the market can be categorised into:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
Cancer Screening Market Trends
The key trends in the global cancer screening market include the rising investments and initiatives by various governments towards improving early cancer diagnostics and treatment protocols. Investments in research and development are expected to bring sophistication to mammography, colonoscopy, and MRI, among others. Increasing penetration of artificial intelligence and machine learning can be seen in the market for cancer screening.
The increasing geriatric population is a key trend propelling the cases of lung cancer and bone cancer. Further, favorable regulations by governments are expected to improve the dynamics of the market for cancer screening in the coming years. In geographical terms, North America accounts for a significant share of the cancer screening market. The advanced healthcare infrastructure across strong economies, the prevalence of cancer, and high levels of general awareness regarding cancer are fuelling the growth of the market.
Key Market Players
The major players in the cancer screening market report include:
- DiaSorin S.p.A.
- Epigenomics AG
- Techlab, Inc.
- Positive Biosciences Limited
- MedGenome Labs Ltd
- 20/20 GeneSystems
The report covers the market shares, capacities, plant turnarounds, expansions, investments, mergers, and acquisitions, among other latest developments of these market players.
Read More Reports:
Lithium-ion Batteries Recycling Market: https://www.openpr.com/news/2887860/global-lithium-ion-batteries-recycling-market-size-to-grow-at
Nickel-Metal Hydride Battery Market: https://www.openpr.com/news/2891261/global-nickel-metal-hydride-battery-market-size-to-grow-at-a-cagr
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: https://www.openpr.com/news/2892107/global-non-steroidal-anti-inflammatory-drugs-nsaids-market
Normal Saline for Parenteral Use Market: https://www.openpr.com/news/2894059/lobal-normal-saline-for-parenteral-use-market-size-to-grow-at
Nuclear Battery Market: https://www.openpr.com/news/2895845/global-nuclear-battery-market-size-to-grow-at-a-cagr-of-8-70-in
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Alex Parker, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA